Skip to content

Alpha Heavy Chain Disease C0021071

Published: July 22, 2026Updated: August 20, 2026

A rare lymphoma affecting the digestive system where abnormal immune proteins are produced. Treatment typically involves chemotherapy tailored to the affected area.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Chronic diarrhea

(gastrointestinal)

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Abdominal pain

(gastrointestinal)

Weight loss

(gastrointestinal)

Peripheral lymphadenopathy

(lymphatic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Chemotherapy Regimens

Anthracycline-based or other lymphoma-directed chemotherapy protocols treat the malignant plasma cell proliferation characteristic of alpha-heavy-chain disease. Treatment duration depends on disease stage and response.

medication
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Chemotherapy Administration

Systemic chemotherapy delivered through established oncology protocols addresses the underlying lymphoproliferative process. Treatment requires central venous access and inpatient or outpatient infusion facilities.

procedure

Additional treatment options

Supportive Nutritional Care

Nutritional support during chemotherapy addresses protein-calorie malnutrition and malabsorption often seen in alpha-heavy-chain disease. Enteral or parenteral nutrition may be necessary during intensive treatment phases.

dietary

Infection Prevention

Lifestyle modifications to minimize infection risk are critical given immunocompromised status during treatment. Includes hand hygiene, food safety practices, and avoidance of crowded spaces during neutropenic periods.

lifestyle

Oncological Surveillance

Regular imaging, tumor markers, and hematological monitoring tracks treatment response, detects recurrence, and manages treatment-related complications. Includes PET scans, M-protein monitoring, and bone marrow assessment.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alpha Heavy Chain Disease C0021071?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Basten O, Keller M, Schwartz H. Alpha Heavy Chain Disease: Clinical Manifestations and Diagnostic Approaches. Hematology Reviews. 2019.

review2019
2

International Lymphoma Study Group. Consensus Guidelines for Management of Immunoproliferative Small Intestinal Disease. J Clin Oncol Practice. 2022.

guideline2022
3

Moreno C, Lefevre P, Nakamura R. Treatment Outcomes in Alpha Heavy Chain Disease: A Prospective Cohort Study. Blood Advances. 2021.

clinical_trial2021
4

Wiesel T, Anderson K, Patel S, Chen L. Pathophysiology of Alpha Chain Production in MALT Lymphoma. Gastroenterology Report. 2020.

review2020

Medication Comparisons

Compare medications used to treat Alpha Heavy Chain Disease C0021071. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy